Insight Pharma Report Announces the Kinase Therapeutics Report

Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
By: Insight Pharma Reports
 
March 10, 2011 - PRLog -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Reports (www.insightpharmareports.com) announces the Kinase Therapeutics: Pipeline Assessment and Commercial Prospects Report authored by, Peter Norman, PhD, MBA.

The number of kinase inhibitors entering clinical development has increased significantly in recent years. In addition to major pharmaceutical and biotech companies, an increasing number of emerging companies are focusing on their development. By 2020, small-molecule kinase inhibitors could generate annual revenues > $25 billion. This report assesses:


•   R&D considerations specific to targeting kinases
•   Current kinase inhibitor pipelines
•   Commercial successes to date
•   Near- and longer-term market outlook
•   Corporate activities of firms involved with kinases


For more information and to purchase this Insight Pharma Report, visit: www.InsightPharmaReports.com

About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  www.InsightPharmaReports.com

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.
End
Source:Insight Pharma Reports
Email:***@healthtech.com Email Verified
Zip:02494
Tags:Life Sciences, Biotech, Pharma, Clinical Development, Kinase Inhibitors, Report, Commercial, Kinase, Pipeline Assessment
Industry:Biotech, Technology, Health
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Insight Pharm Reports PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share